Biologically active, hemagglutinin from type A Clostridium...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S234100, C424S239100, C424S236100, C424S203100, C514S002600, C530S350000, C530S825000

Reexamination Certificate

active

06994859

ABSTRACT:
An isolated, biologically active 33 kDa hemagglutinin purified from the type AClostridium botulinumneurotoxin complex and its uses are described.

REFERENCES:
patent: 5512547 (1996-04-01), Johnson et al.
patent: 6203794 (2001-03-01), Dolly et al.
patent: 93/05800 (1993-04-01), None
patent: 0 593 176 (1994-04-01), None
patent: 0 770 395 (1997-05-01), None
patent: 94/28923 (1994-12-01), None
patent: WO 94/28922 (1994-12-01), None
patent: 95/17904 (1995-07-01), None
patent: 95/30431 (1995-11-01), None
patent: 95/32738 (1995-12-01), None
patent: 97/35604 (1997-10-01), None
Fu et al. In: 5th PAN American Symposium on Animal Plant and Microbial Toxins, Frederick, MD, Jul. 30-Aug. 4, 1995, p. 76.
Fujita et al. FEBS Lett. 376:41-44, 1995.
Sambrook et al. Molecular Cloning—A Laboratory Manual, Second Edition, Cold Spring Harbor, pp. 17.2-17.44, 1989.
Walker B. In: Peptide Antigens: A Practical Approach, (Ed) Wisdon GB. IRL Press, Oxford University Press, New York, pp. 27-81, 1994.
Dasgupta and Borozz, Biochim. Biophys. Acta. 147: 603-605, 1967.
Dasgupta et al. Biochim. Biophys. Acta. 168:522-531, 1968.
Binz et al., “The Complete Sequence of Botulinum . . . ,” The Journal of Biological Chemistry, 265:9153-9158, 1990.
East et al., “Cloning and Sequencing . . . ,” System Appl. Microbiol., 17:306-312, 1994.
East et al., “Conserved Structure of . . . ,” Current Microbiology, 29:69-77, 1994.
Inoue et al., “Molecular Composition . . . ,” Infection and Immunity, 64:1589-1594, 1996.
Sharma et al., “A Direct Binding . . . ,” Abstract of the 97thGeneral Meeting of the American Society for Microbiology p. 440, p-23, 1997.
Singh et al., “Molecular Composition . . . ,” 2ndInternational Meeting of the Molecular Genetics & Pathogenesis of Clostridia p. 40, 6:22-25, 1997.
Singh et al., “Physicochemical and . . . ,” Journal of Protein Chemistry, 14:7-18, 1995.
Sharma et al., “Immunological Properties . . . ,” Protein Science Ninth Symposium Program & Abstracts p. 110, 269-S, 7:8-12, 1995.
Somers et al., “Clostridium Botulinum . . . ,” Journal of Protein Chemistry, 10:415-425, 1991.
Sakaguchi, “Closridium Botulinum . . . ,” Pharmac. Ther., 19:165-194, 1983.
Sharma et al., “Clostridium Botulinum . . . ,” University of Massachusetts Dartmouth Third Annual Sigma Xi Research Exhibit, Apr., 1997.
Dasgupta et al., Toxicon, 22:415-424.
Tsuzuki et al., Infect. Immun., 58:3173-3177, 1990.
Fu et al., J. Protein Chem., 17:53-60, 1998.
Sharma et al., J. Nat. Toxins, 7:239-253, 1998.
Tse et al., European J. Biochem., 122:493-500, 1982.
Simpson et al., “Isolation and characterization . . . ,” Meth. Enzymol, 165:76-85.
Fu et al., In: 5thPan American Symposium on Animal Plant and Microbial Toxins, Frederick, MD, Jul. 30 to Aug. 4, abstract, p. 76.
Shukla et al., In: Abstracts of the 97thGeneral Meeting of the Aerican Society of Microbiology, Miami Beach, May 4-8, abstract K-127, p. 363, 1997.
Lindo et al., In: Program and Abstracts of the 11thSymposium of the Protein Society, Boston, MA, Jul. 12-16, Cambridge University press, abstract 267-S, p. 100, 1997.
Fu., Dissertation Abstracts International, vol. 58, No. 9B, abstracts, 1997.
Vinogradova et al., Biokhimiia, 48:788-796, 1983.
Ashton et al., Toxicon, 23:235-246, 1985.
Shone et al., Appl. Environ. Microbiol, 50:63-67, 1985.
Hambleton, J. Neurol, 239:16-20, abstract, 1992.
Sharma et al., In: Abstracts of the 11thSymposium of the Protein Society, Boston, MA, Jul. 12-16, abstract 262-M, p. 99.
Singh et al., Toxicon, 34:737-742, 1996.
Singh et al., Toxicon, 34:267-275, 1996.
Sing et al., Toxicon, 33:1541-1547, 1995.
Sharma et al., J. Protein Chem., 18:-9-38, Jan., abstract, 1999.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Biologically active, hemagglutinin from type A Clostridium... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biologically active, hemagglutinin from type A Clostridium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active, hemagglutinin from type A Clostridium... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3647751

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.